<div id="readability-page-1"><p dir="ltr"><span>Linde PLC (LIN) moved up by 3.33%. The Chemicals sector is up by 0.87%. The company outperformed the industry. Top 3 stocks by turnover in the sector: Linde PLC (LIN) up 3.33%; Dow Inc (DOW) down 0.89%; LyondellBasell Industries NV (LYB) down 2.18%.</span></p><p><img src="https://imageproxy.pbkrs.com/https://resource.tradingkey.com/ai/wkrepot/802f3690-6076-4d30-adb0-c0bb47c6ebd4_1777644920.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="800" height="488" original-src="https://imageproxy.pbkrs.com/https://resource.tradingkey.com/ai/wkrepot/802f3690-6076-4d30-adb0-c0bb47c6ebd4_1777644920.png"/></p><h2>What is driving Linde PLC (LIN)’s stock price up today?</h2><p>The positive stock movement for Linde plc (LIN) on May 1, 2026, is primarily attributed to its strong first-quarter 2026 financial results, which surpassed analyst expectations. The company reported adjusted earnings per share and revenue that both exceeded consensus estimates. Adjusted EPS was reported at $4.33, beating analyst forecasts that ranged from $4.26 to $4.31. Similarly, revenue of $8.78 billion outperformed expectations of $8.60 billion to $8.67 billion. These positive financial indicators suggest robust operational performance, contributing to investor confidence.</p> <p>Underlying sales for the quarter increased, driven by both price attainment and volume growth, with a notable contribution from project start-ups. The company's adjusted operating profit margin remained strong at 30.0%, demonstrating effective cost management and pricing power. Furthermore, Linde returned a significant amount to shareholders through dividends and stock repurchases, reinforcing its commitment to shareholder value.</p> <p>Despite the strong first-quarter performance, the stock experienced some intraday volatility. This could be linked to the company's full-year 2026 adjusted EPS guidance, which, while still projecting growth, had a midpoint that came in slightly below some analyst consensus estimates. The company provided full-year guidance of $17.60 to $17.90, with a midpoint of $17.75, whereas some analyst estimates were around $17.80 to $17.84. This minor discrepancy in the outlook for the remainder of the year may have introduced some caution and contributed to the observed intraday fluctuations. However, the positive beat on current quarter results largely overshadowed these concerns, leading to the overall upward price movement. Linde's strategic focus on decarbonization, semiconductors, and healthcare demand, along with a substantial project backlog, continues to support a positive long-term outlook.</p><h2>Technical Analysis of Linde PLC (LIN)</h2><p dir="ltr"><span>Technically, Linde PLC (LIN) shows a MACD (12,26,9) value of [3.65], indicating a neutral signal. The RSI at 51.64 suggests neutral condition and the Williams %R at -52.44 suggests oversold condition. Please monitor closely.</span></p><h2>Fundamental Analysis of Linde PLC (LIN) </h2><p dir="ltr"><span>Linde PLC (LIN) is in the Chemicals industry. Its latest annual revenue is $33.99B, ranking 2 in the industry. The net profit is $6.90B, ranking 1 in the industry. Company Profile</span></p><p><img src="https://imageproxy.pbkrs.com/https://resource.tradingkey.com/ai/wkrepot/70f5c703-25cd-4c67-9133-fc96af3f3caa_1777644925.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="800" height="402" original-src="https://imageproxy.pbkrs.com/https://resource.tradingkey.com/ai/wkrepot/70f5c703-25cd-4c67-9133-fc96af3f3caa_1777644925.png"/></p><p dir="ltr"><span>Over the past month, multiple analysts have rated the company as Buy, with an average price target of $530.28, a high of $580.00, and a low of $472.33.</span></p><h2>More details about Linde PLC (LIN)</h2><p>Company Specific Risks:</p> <ul> <li>Concerns persist regarding Linde's valuation, as highlighted by a JPMorgan downgrade in February from Overweight to Neutral due to the stock exceeding its price target, and further commentary in April indicating limited upside potential given current high multiples.</li> <li>The company faces challenges from stagnant average consolidated sequential pricing for two consecutive quarters, a trend primarily influenced by declining helium prices, which was a key factor in an analyst downgrade in February and poses a risk to earnings growth.</li> <li>Linde's full-year 2026 adjusted earnings per share guidance, issued in February, fell below consensus analyst expectations, contributing to an immediate stock decline and suggesting a more modest growth outlook for the upcoming year.</li> </ul><p>Find out more</p></div>

<p>Linde PLC (LIN) saw a stock increase of 3.33% on May 1, 2026, driven by strong Q1 financial results that exceeded analyst expectations. Adjusted EPS was $4.33, and revenue reached $8.78 billion. Despite some intraday volatility linked to slightly lower full-year EPS guidance, investor confidence remains high due to robust operational performance and a commitment to shareholder value. Analysts rate Linde as a Buy, with an average price target of $530.28. However, concerns about valuation and stagnant pricing trends pose risks to future earnings growth.</p>

TradingKey

Linde

Lyondellbasell Industries NV

JPMorgan Chase

Linde plc

JPMORGAN CHASE & CO. 4.20% DEP SHS REPSTG 1/400TH PFD SER MM

JPMORGAN CHASE & CO. 6%NON CUM DEP SHS REP 1/400TH PFD SER EE

JPMORGAN CHASE & CO. DEP REP 1/400TH (5.75% NON CUM PFD DD)

JPMORGAN CHASE & CO. 4.625% DEP SH RE 1/400TH INT NO CU PF LL

JPMorgan Chase & Co.

JPMORGAN CHASE & CO. 4.55% DEP SHS REPSTG 1/400TH PFD SER JJ

JPMORGAN CHASE & CO. 4.75 DEP SHS REP 1/400 NCUM PFD SR GG

Linde PLC Stock (LIN) Moved Up by 3.33% on May 1: What Investors Need To Know